External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology Retina Society 2021
Roche and Genentech at

Retina Society 2021

September 29 - October 02
Virtual
retinasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:20 AM
Duration 6mins Virtual
Efficacy, Safety, and Durability of Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): 48-Week Results From the Phase 3 TENAYA and LUCERNE Trials
Ferrone P, Heier J, Quezada Ruiz C, Lin H, Silverman D, Ives J, Basu K, Wong T
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:02 PM
Duration 6mins Virtual
Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Eichenbaum DA, Wykoff CC, Haskova Z, Lin H, Silverman D, Ives J, Basu K, Tadayoni R
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins Virtual
The Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular Age-Related Macular Degeneration (nAMD): Updated Safety and Efficacy Results
Clark L, Barteselli G, Fung AE, Kaufman D, Makadia S, Morral M, Willis J, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:54 AM
Duration 6mins Virtual
Exploring Ang-2 Signaling in Vascular Stability in Patients With DME Receiving Faricimab in Phase 2 and Phase 3 Trials
Baumal C, Loewenstein A, Sheth V, Csaky K, Edmonds R, Chang M, Willis J, Haskova Z, Westenkow P
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.